Trial
NCT00651807
A Trial to Investigate the Effectiveness and Safety of Org 3236 (Etonogestrel) Tablets in Men With Urinary Complaints Suggestive of a Benign Enlargement of the Prostate (304001)(P05806)
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Organon and Co
Collaborators
—
Condition
Benign Prostatic Hyperplasia (BPH)
Intervention
etonogestrel
Why stopped
Business Reasons
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-04-08